Your browser doesn't support javascript.
loading
A novel retroauricular fixed port for hemodialysis: surgical procedure and preliminary results of the clinical investigation.
Caversaccio, Marco; Wimmer, Wilhelm; Widmer, Matthias; Bachtler, Matthias; Kalicki, Robert; Uehlinger, Dominik; Arnold, Andreas.
Afiliação
  • Caversaccio M; a Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Wimmer W; b Hearing Research Laboratory, ARTORG Center, University of Bern, Bern, Switzerland.
  • Widmer M; a Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Bachtler M; b Hearing Research Laboratory, ARTORG Center, University of Bern, Bern, Switzerland.
  • Kalicki R; c Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Uehlinger D; a Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Arnold A; c Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Acta Otolaryngol ; 139(2): 129-134, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30714444
ABSTRACT

BACKGROUND:

Inspired by bone conduction implants, which have a low infection rate, a bone-anchored port (BAP) system for hemodialysis was designed.

OBJECTIVES:

To demonstrate the surgical procedure for the BAP and to present preliminary results of the clinical investigation. MATERIALS AND

METHODS:

Patients with end-stage renal disease and contraindications for an arteriovenous forearm fistula were recruited for BAP implantation. A workflow specifically developed for implantation was followed. Postoperative evolution, the dialysis procedure, the functionality of the implant, and signs of infection were monitored.

RESULTS:

So far, five patients have been implanted with the BAP system. Hemodialysis with the BAP was unproblematic in all five patients, on average starting from the 9th day after implantation (range 2 to 15 days). Up to now, 1789 cumulative patient days (average 355 days, range 154 to 448 days) have been recorded. One patient died 14 months after implantation, from a cardiac arrest unrelated to the system. Dialysis was painless, and no catheter-related infections have occurred.

CONCLUSION:

BAP implantation can be safely performed but requires an interdisciplinary team. No infections related to the device have occurred.

SIGNIFICANCE:

The presented system is a promising addition to the choices of vascular accesses for hemodialysis patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diálise Renal / Âncoras de Sutura / Dispositivos de Acesso Vascular / Falência Renal Crônica / Processo Mastoide Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diálise Renal / Âncoras de Sutura / Dispositivos de Acesso Vascular / Falência Renal Crônica / Processo Mastoide Idioma: En Ano de publicação: 2019 Tipo de documento: Article